Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 2275 of 3284 entries
View as:

Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT00528905 Org: User:
Start: 08/31/07 End: 11/30/08 Due: 11/30/09

Symbicort Maintenance and Reliever Therapy - Experience in Real Life Setting in Malaysia

Phase: N/A Priority: Normal
NCT ID: NCT00576316 Org: User:
Start: 01/31/08 End: 11/30/08 Due: 11/30/09

IRESSA™ (Gefitinib) With Cisplatin Plus Radiotherapy for the Treatment of Previously Untreated Unresected Late Stage III/IV Non-Metastatic Head and Neck Squamous Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT00229723 Org: User:
Start: 11/30/04 End: 06/30/08 Due: 06/30/09

Study of Durvalumab Plus Tremelimumab as First-line Treatment in Chinese Patients With Unresectable Hepatocellular Carinoma

Phase: N/A Priority: Normal
NCT ID: NCT05557838 Org: User:
Start: 02/22/23 End: 03/31/25 Due: 03/31/26

Ticagrelor China Pharmacokinetic/Pharmacodynamic Study

Phase: N/A Priority: Normal
NCT ID: NCT02064985 Org: User:
Start: 02/28/14 End: 11/30/14 Due: 11/30/15

The FLASH Study: A Study of Roflumilast Versus Placebo in Patients With Asthma (BY217/M2-023)

Phase: N/A Priority: Normal
NCT ID: NCT00076076 Org: User:
Start: 12/31/03 End: 06/30/05 Due: 06/30/06

Gemini Symbicort pMDI

Phase: N/A Priority: Normal
NCT ID: NCT00646516 Org: User:
Start: 10/31/03 End: 02/28/05 Due: 02/28/06

Evaluate Efficacy and Safety of Saxagliptin in Adult Patients With Type 2 Diabetes Inadequate Glycemic Control

Phase: N/A Priority: Normal
NCT ID: NCT00698932 Org: User:
Start: 06/30/08 End: 10/31/09 Due: 10/31/10

Pharmacokinetics, Safety and Tolerability of Twice-Daily Aclidinium Bromide/Formoterol Fumarate Fixed Dose Combination in Chinese Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease

Phase: N/A Priority: Normal
NCT ID: NCT03276078 Org: User:
Start: 11/23/17 End: 06/12/18 Due: 06/12/19

FASENRA SCEI for Long-term Use

Phase: N/A Priority: Normal
NCT ID: NCT03588546 Org: User:
Start: 05/31/18 End: 09/10/24 Due: 09/10/25

Management of Index Episode in Patients With Bipolar Disorder Treated by Seroquel XR

Phase: N/A Priority: Normal
NCT ID: NCT01029145 Org: User:
Start: 12/31/09 End: 05/31/10 Due: 05/31/11

A Study to Investigate the Pharmacokinetics of Midazolam After Repeated Doses of Camizestrant (AZD9833) and to Investigate the Pharmacokinetics of Camizestrant When Administered Alone and in Combination With Carbamazepine in Healthy Post-Menopausal Female Participants

Phase: N/A Priority: Normal
NCT ID: NCT06547164 Org: User:
Start: 08/27/24 End: 07/30/25 Due: 07/30/26

Phase Ib Study of the Safety of T-DXd and Immunotherapy Agents With and Without Chemotherapy in Advanced or Metastatic HER2+, Non-squamous NSCLC

Phase: N/A Priority: Normal
NCT ID: NCT04686305 Org: User:
Start: 03/09/21 End: 12/23/25 Due: 12/23/26

A Cross Sectional Disease/Condition Focused Observational Study on Chronic Obstructive Pulmonary Disease (COPD)

Phase: N/A Priority: Normal
NCT ID: NCT02100332 Org: User:
Start: 11/30/12 End: 07/31/14 Due: 07/31/15

The Study Will Evaluate the Efficacy of AZD5423 in Patients With Mild Asthma Challenged With an Inhaled Allergen

Phase: N/A Priority: Normal
NCT ID: NCT01225549 Org: User:
Start: 11/30/10 End: 12/31/11 Due: 12/31/12

Drug-Drug Interaction Study of Esomeprazole (D961H) Capsule and Loxoprofen Tablet After Repeated Oral Administration in Japanese Males

Phase: N/A Priority: Normal
NCT ID: NCT00676117 Org: User:
Start: 04/30/08 End: 07/31/08 Due: 07/31/09

A Retrospective Cohort Study of Acute Pancreatitis in Relation to Use of Exenatide and Other Antidiabetic Agents

Phase: N/A Priority: Normal
NCT ID: NCT01077323 Org: User:
Start: 09/30/04 End: 03/31/08 Due: 03/31/09

Non-interventional, Prospective Study to Determine Prevalence of EGFR Mutations in Non-small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04742192 Org: User:
Start: 03/04/21 End: 11/30/22 Due: 11/30/23

A Phase I/IIa Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of AZD0022 as Monotherapy and in Combination With Anti-cancer Agents in Adult Participants With Tumours Harbouring a KRASG12D Mutation

Phase: N/A Priority: Normal
NCT ID: NCT06599502 Org: User:
Start: 10/18/24 End: 01/20/28 Due: 01/20/29

Phase I, Open-label, Dose-escalation, Safety and PK Study of AZD6918

Phase: N/A Priority: Normal
NCT ID: NCT00733031 Org: User:
Start: 08/31/08 End: 03/31/09 Due: 03/31/10

Study to Compare Different Formulations of AZD3355

Phase: N/A Priority: Normal
NCT ID: NCT00688402 Org: User:
Start: 04/30/08 End: 06/30/08 Due: 06/30/09

A Placebo Controlled Study Comparing AZD1775+ Docetaxel Versus Placebo+Docetaxel to Treat Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02087176 Org: User:
Start: 03/31/14 End: 05/31/15 Due: 05/31/16

A Phase I Study of AZD1480 in Patients With Advanced Solid Malignancies and Advanced Hepatocellular Carcinoma in the Escalation Phase,Non-Small Cell Lung Cancer(NSCLC) and Non-smokers With Lung Metastasis and Gastric Cancer and Solid Tumour in the Expansion Phase.

Phase: N/A Priority: Normal
NCT ID: NCT01219543 Org: User:
Start: 11/30/10 End: 12/31/12 Due: 12/31/13

Epidemiology of Chronic Bronchitis in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Phase: N/A Priority: Normal
NCT ID: NCT02128529 Org: User:
Start: 10/31/10 End: 04/30/11 Due: 04/30/12

Study to Assess the Efficacy and Safety of AZD1981 in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)

Phase: N/A Priority: Normal
NCT ID: NCT00690482 Org: User:
Start: 05/31/08 End: 12/31/08 Due: 12/31/09